NEW YORK (GenomeWeb News) – VisionGate will use semiconductor developer MathStar’s technology to develop a medical imaging solution for cellular characterization that would be used to scan cells in patients at risk of cancer, MathStar said today.
 
Under the agreement, VisionGate will use MathStar’s Arrix FPOA chip as the processing engine for its Cell-CT platform, which is entering investigational clinical trials, MathStar said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.